27.65
price down icon2.61%   -0.74
 
loading
前日終値:
$28.39
開ける:
$28.25
24時間の取引高:
1.09M
Relative Volume:
1.16
時価総額:
$2.82B
収益:
-
当期純損益:
$-804.34M
株価収益率:
-2.9384
EPS:
-9.41
ネットキャッシュフロー:
$-531.06M
1週間 パフォーマンス:
-3.12%
1か月 パフォーマンス:
-24.33%
6か月 パフォーマンス:
-45.78%
1年 パフォーマンス:
-49.44%
1日の値動き範囲:
Value
$26.57
$28.50
1週間の範囲:
Value
$26.57
$31.18
52週間の値動き範囲:
Value
$26.57
$55.72

Biohaven Ltd Stock (BHVN) Company Profile

Name
名前
Biohaven Ltd
Name
セクター
Healthcare (1166)
Name
電話
203-404-0410
Name
住所
215 CHURCH STREET, NEW HAVEN, CT
Name
職員
256
Name
Twitter
@biohavenpharma
Name
次回の収益日
2022-11-07T13:30:00.000Z
Name
最新のSEC提出書
Name
BHVN's Discussions on Twitter

BHVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BHVN
Biohaven Ltd
27.65 2.82B 0 -804.34M -531.06M -9.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-11 開始されました Deutsche Bank Buy
2024-09-16 開始されました Jefferies Buy
2024-09-04 開始されました Bernstein Outperform
2024-07-24 開始されました Morgan Stanley Overweight
2024-02-16 開始されました RBC Capital Mkts Outperform
2024-02-06 開始されました UBS Buy
2023-12-22 開始されました H.C. Wainwright Buy
2023-12-08 開始されました Robert W. Baird Outperform
2023-01-24 開始されました SVB Securities Outperform
2023-01-04 開始されました JP Morgan Overweight
2022-12-02 開始されました BTIG Research Buy
2022-10-26 アップグレード Cantor Fitzgerald Neutral → Overweight
2022-10-12 開始されました Piper Sandler Overweight
2022-08-19 ダウングレード Piper Sandler Overweight → Neutral
2022-08-08 ダウングレード Wedbush Outperform → Neutral
2022-05-11 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-10-19 再開されました Morgan Stanley Equal-Weight
2021-08-10 ダウングレード UBS Buy → Neutral
2021-08-03 繰り返されました Canaccord Genuity Buy
2021-03-11 開始されました UBS Buy
2020-12-15 開始されました H.C. Wainwright Buy
2020-04-17 開始されました Cowen Outperform
2020-02-10 ダウングレード Oppenheimer Outperform → Perform
2020-02-06 開始されました Mizuho Buy
2019-11-22 開始されました Wedbush Outperform
2019-06-25 繰り返されました Canaccord Genuity Buy
2019-05-06 開始されました Goldman Buy
2019-04-09 ダウングレード Morgan Stanley Overweight → Equal-Weight
2019-03-04 繰り返されました Needham Buy
2018-07-03 繰り返されました Needham Buy
2018-07-02 繰り返されました Needham Buy
2018-04-05 ダウングレード Barclays Overweight → Equal Weight
2018-02-22 繰り返されました Canaccord Genuity Buy
2017-12-15 開始されました Canaccord Genuity Buy
2017-10-03 繰り返されました Needham Buy
すべてを表示

Biohaven Ltd (BHVN) 最新ニュース

pulisher
Mar 28, 2025

Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com Australia

Mar 28, 2025
pulisher
Mar 25, 2025

Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR

Mar 25, 2025
pulisher
Mar 22, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Major Player in the Multiple System Atrophy (MSA) Market - openPR

Mar 21, 2025
pulisher
Mar 20, 2025

Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart

Mar 20, 2025
pulisher
Mar 20, 2025

Multiple System Atrophy Market to Reach New Heights in Growth - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider

Mar 19, 2025
pulisher
Mar 19, 2025

How To Trade (BHVN) - Stock Traders Daily

Mar 19, 2025
pulisher
Mar 18, 2025

Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow

Mar 18, 2025
pulisher
Mar 18, 2025

Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider

Mar 16, 2025
pulisher
Mar 16, 2025

Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal

Mar 16, 2025
pulisher
Mar 15, 2025

Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire

Mar 15, 2025
pulisher
Mar 14, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 12, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 11, 2025
pulisher
Mar 10, 2025

ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 10, 2025

Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St

Mar 10, 2025
pulisher
Mar 09, 2025

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 09, 2025
pulisher
Mar 09, 2025

Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

How to Take Advantage of moves in (BHVN) - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com

Mar 08, 2025
pulisher
Mar 07, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - Markets Insider

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Piper Sandler maintains Biohaven stock with $76 target - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Private Advisor Group LLC - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $68.00 - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven FY2025 EPS Forecast Reduced by Cantor Fitzgerald - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Morgan Stanley cuts Biohaven stock price target to $63 from $69 By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Investors to Reach Out - Markets Insider

Mar 06, 2025
pulisher
Mar 06, 2025

Morgan Stanley cuts Biohaven stock price target to $63 from $69 - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Optimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline Advancements - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Royal Bank of Canada Reaffirms “Outperform” Rating for Biohaven (NYSE:BHVN) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

HC Wainwright Reiterates Buy Rating for Biohaven (NYSE:BHVN) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Director Makes Major Move with Biohaven Ltd. Stock Purchase - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Stockholders to Reach Out - Markets Insider

Mar 05, 2025
pulisher
Mar 05, 2025

Biohaven director John Childs acquires shares worth $996,238 By Investing.com - Investing.com South Africa

Mar 05, 2025

Biohaven Ltd (BHVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):